ArticleScientific reports2025
A novel acidic deep eutectic solvent for sustainable and efficient coumarin synthesis.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Molecular interactions, solubility, and cytotoxic activity of 4‑hydroxycoumarin in choline chloride‑based acidic deep eutectic solvents.Scientific reports · 2026Article
- Synthesis of Pyridines, Quinazolinones and Coumarins in Deep Eutectic Solvents: Principles, Methods and Applications.Molecules (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A novel acidic deep eutectic solvent (ADES) has been developed as an efficient and sustainable alternative to traditional solvents and catalysts in organic synthesis. The ADES was synthesized through a simple one-pot procedure involving benzyl chloride, 2-(dimethylamino)ethanol, and p-toluenesulfonic acid, yielding a homogeneous liquid. Structural and compositional characterization was performed using FTIR and NMR spectroscopy. The catalytic performance of the synthesized ADES was evaluated in the Pechmann condensation for the synthesis of coumarins. The reaction proceeded under mild conditions using commercially available starting materials, with reaction times ranging from 5 to 200 min and isolated yields between 72% and 97%. The process is operationally simple and readily scalable, indicating its suitability for industrial implementation. Importantly, the ADES demonstrated excellent recyclability, maintaining catalytic activity over five consecutive cycles without significant loss of efficiency which makes it an environmentally friendly and economically viable option for large-scale synthesis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.